We hypothesize that high expression of YAP and AR may be associated with advanced tumor stage, metastasis, and poorer progression-free survival (PFS), making them valuable prognostic indicators and potential therapeutic targets in osteosarcoma. Here, AR is linked to osteosarcoma.